Genetic-testing company, Invitae (NYSE: NVTA), isn't as easy to understand as it might seem. After more than a year of pivoting and scaling down its operations, changing its leadership, and ...

Invitae (NYSE: NVTA) delivered a sizzling performance in 2020, with its shares skyrocketing 159%. That sizzle fizzled somewhat last month, though, after the medical genetics company announced a ...

SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will host an investor conference call on Wednesday, October 7 at 4:30 p.m.

Hi, everyone. Good afternoon. Thanks for joining us here. If you don't know me, my name is Andrew Brackmann, I cover diagnostics for William Blair. This afternoon, we have Invitae joining us. We have ...

Hello, everyone, and welcome to the Invitae first quarter 2023 financial results conference call. My name is Emily, and I will be your conference coordinator today. [Operator instructions] I will now ...

Hello, everybody, and welcome to the Invitae Fourth Quarter 2020 Financial Results Conference Call. My name is Sam, and I will be coordinating your call today. [Operator Instructions] I would now like ...

Invitae's stock is down and it might get delisted from its stock exchange. It has a new crop of top managers, but it's running low on cash. The company doesn't look good right now, but with enough ...